Literature DB >> 6119362

Inhibition by somatostatin of bovine growth hormone secretion following sodium channel activation.

R J Bicknell, J G Schofield.   

Abstract

1. Growth hormone secretion, exchangeable cellular sodium and calcium concentrations measured by 22Na and 45Ca incorporation, and efflux of 45Ca were studied in dispersed bovine anterior pituitary cells. 2. Addition of veratridine (100 microM), an activator of sodium channels, increased exchangeable sodium and calcium concentrations in the cells, the efflux of 45Ca from prelabelled cells, and caused a biphasic stimulation of the rate of growth hormone secretion. Secretion of growth hormone was not stimulated when the extracellular calcium was decreased below 0.1 mM. 3. The increases in growth hormone secretion, exchangeable calcium concentration and 45Ca efflux from prelabelled cells caused by veratridine were abolished by addition of the calcium antagonist verapamil (20 microM). Verapamil also reduced the rise in exchangeable sodium caused by veratridine and increased the resting exchangeable sodium concentrations. 4. The peptide somatostatin (1 micrograms/ml) prevented veratridine-stimulated growth hormone secretion but did not inhibit the increases in exchangeable sodium and calcium caused by veratridine. The peptide itself elicited a transient increase in 45Ca efflux and subsequently partially inhibited veratridine-stimulated 45Ca efflux. 5. The data suggest that anterior pituitary cells possess voltage-sensitive sodium channels. Activation of these channels by veratridine may lead to depolarization and increased entry of calcium via potential-dependent calcium channels, which contributes to a rise in cytoplasmic calcium concentration and the subsequent stimulation of growth hormone secretion. We conclude that the calcium antagonist verapamil may also interact with sodium channels, and that the peptide somatostatin may act on growth-hormone-secreting cells either to prevent the rise in cytoplasmic calcium by hyperpolarizing the cells or to decrease the affinity of a population of calcium binding sites in the cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6119362      PMCID: PMC1248137          DOI: 10.1113/jphysiol.1981.sp013774

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  34 in total

1.  Sodium and calcium action potential in pituitary cells.

Authors:  B Biales; M A Dichter; A Tischler
Journal:  Nature       Date:  1977-05-12       Impact factor: 49.962

2.  Reversal of somatostatin inhibition of insulin secretion by calcium.

Authors:  D L Curry; L L Bennett
Journal:  Biochem Biophys Res Commun       Date:  1974-10-08       Impact factor: 3.575

3.  Inhibition of adenosine 3',5'-monophosphate accumulation in anterior pituitary gland in vitro by growth hormone-release inhibiting hormone.

Authors:  P Borgeat; F Labrie; J Drouin; A Bélanger; H Immer; K Sestanj; V Nelson; M Götz; A V Schally; D H Coy; E J Coy
Journal:  Biochem Biophys Res Commun       Date:  1974-02-27       Impact factor: 3.575

4.  Effects of various secretagogues upon 42K and 22NA uptake during in vitro hormone release from the rat adenohypophysis.

Authors:  J Kraicer; J V Milligan
Journal:  J Physiol       Date:  1973-07       Impact factor: 5.182

5.  Somatostatin inhibition of rat growth hormone release in vitro in the presence of BaCl2 or 3-isobutyl-1-methylxanthine.

Authors:  J G Schofield; F Mira-Moser; M Schorderet; L Orci
Journal:  FEBS Lett       Date:  1974-09-15       Impact factor: 4.124

Review 6.  The effect of veratridine on excitable membranes of nerve and muscle.

Authors:  W Ulbricht
Journal:  Ergeb Physiol       Date:  1969

7.  Differentiation of the transmembrane Na and Ca channels in mammalian cardiac fibres by the use of specific inhibitors.

Authors:  M Kohlhardt; B Bauer; H Krause; A Fleckenstein
Journal:  Pflugers Arch       Date:  1972       Impact factor: 3.657

8.  ATP-dependent Ca++-extrusion from human red cells.

Authors:  H J Schatzmann
Journal:  Experientia       Date:  1966-06-15

9.  The effect of veratridine on the release of catecholamines from the perfused adrenal gland.

Authors:  S Ito; Y Nakazato; A Ohga
Journal:  Br J Pharmacol       Date:  1979-02       Impact factor: 8.739

10.  Effects of veratridine on Ca fluxes and the release of oxytocin and vasopressin from the isolated rat neurohypophysis.

Authors:  J J Nordmann; R E Dyball
Journal:  J Gen Physiol       Date:  1978-09       Impact factor: 4.086

View more
  2 in total

1.  Veratridine modifies the gating of human voltage-gated sodium channel Nav1.7.

Authors:  Xiao-Yu Zhang; Rui-Yun Bi; Peng Zhang; Ye-Hua Gan
Journal:  Acta Pharmacol Sin       Date:  2018-06-27       Impact factor: 6.150

2.  Electrophysiological evidence of RML12 mosquito cell line towards neuronal differentiation by 20-hydroxyecdysdone.

Authors:  Julie Gaburro; Jean-Bernard Duchemin; Prasad N Paradkar; Saeid Nahavandi; Asim Bhatti
Journal:  Sci Rep       Date:  2018-07-04       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.